The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer. - Suppr | 超能文献

The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.

作者信息

Stewart H J, Forrest A P, Gunn J M, Hamilton T, Langlands A O, McFadyen I J, Roberts M M

出版信息

Eur J Cancer (1965). 1980;Suppl 1:83-8.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.

Eur J Cancer (1965). 1980;Suppl 1:83-8.

2

The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer.

Clin Oncol. 1979 Sep;5(3):251-6.

3

Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.

Eur J Cancer (1965). 1980;Suppl 1:107-10.

4

CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.

Eur J Cancer (1965). 1980;Suppl 1:119-23.

5

Adjuvant endocrine therapy of primary operable breast cancer. Report on the Copenhagen breast cancer trials.原发性可手术乳腺癌的辅助内分泌治疗。哥本哈根乳腺癌试验报告。

Eur J Cancer (1965). 1980;Suppl 1:183-7.

6

Tamoxifen and fluoxymesterone in advanced breast cancer: a controlled clinical trial.他莫昔芬与氟羟甲睾酮治疗晚期乳腺癌：一项对照临床试验。

Cancer Treat Rep. 1980 Jan;64(1):117-21.

7

Preliminary report of a controlled trial in advanced breast cancer comparing tamoxifen with conventional hormone therapy.

Cancer Treat Rep. 1976 Oct;60(10):1461-2.

8

DES versus tamoxifen in advanced breast cancer.

N Engl J Med. 1981 Apr 23;304(17):1041-3. doi: 10.1056/NEJM198104233041714.

9

Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.氨鲁米特与他莫昔芬治疗转移性乳腺癌的随机试验。

Cancer Res. 1982 Aug;42(8 Suppl):3434s-3436s.

10

[Mechanism and classification of hormone therapy for human breast cancer studied by changes of SHBG binding capacity].[通过性激素结合球蛋白结合能力变化研究人乳腺癌激素治疗的机制与分类]

Gan No Rinsho. 1984 Dec;30(15):1879-82.

引用本文的文献

1

Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer.雌激素治疗诱导未折叠蛋白反应以驱动 ER+ 乳腺癌细胞死亡。

Mol Oncol. 2019 Aug;13(8):1778-1794. doi: 10.1002/1878-0261.12528. Epub 2019 Jul 9.

2

Estrogen as therapy for breast cancer.雌激素作为乳腺癌的治疗方法。

Breast Cancer Res. 2002;4(4):133-6. doi: 10.1186/bcr436. Epub 2002 May 15.

3

On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.关于他莫昔芬、醋酸甲羟孕酮和氨鲁米特联合激素单一疗法在晚期乳腺癌中的作用

Klin Wochenschr. 1987 Oct 15;65(20):959-66. doi: 10.1007/BF01717830.